Skip to content
Clinical Trials – home
Therapeutic area

Psychiatric disorders – page 38

  • 548 clinical trials
  • 257 recruiting
  • 147 conditions
  • 26 countries

Conditions in this area

147 conditions with trials, the busiest first

Clinical trials in Psychiatric disorders

548 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

548 clinical trials

Depression

Not recruiting

Study on Psilocybin for Patients with Treatment-Resistant Depression

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Psilocybine
  • Sponsor:Centre Hospitalier Universitaire De Nimes

Study on the Effects of GSL-01-001 for Patients with Irritable Bowel Syndrome (IBS) Type D

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Cannabidiol
  • Sponsor:Cannabibs Sp. z o.o.

Major depression

Not recruiting

Study on the Safety and Effectiveness of Aticaprant with Antidepressants for Adults and Elderly with Major Depressive Disorder

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Aticaprant
  • Sponsor:Janssen Cilag International

Rett syndrome

Not recruiting

Study on the Safety and Tolerability of Leriglitazone for Children with Rett Syndrome

Investigational
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Leriglitazone
  • Sponsor:Minoryx Therapeutics S.L.

Insomnia

Not recruiting

Study to Determine Safe and Effective Dose of Daridorexant for Treating Insomnia in Children and Adolescents Aged 10 to 18 Years

Registered drug
Countries:BulgariaBulgaria
  • Participants:0–17 years
  • Substances:Daridorexant
  • Sponsor:Idorsia Pharmaceuticals Ltd.
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Semaglutide
  • Sponsor:Psykiatrisk Center Kobenhavn

Drug use disorder

Not recruiting

Study of Intranasal Oxytocin Treatment for Patients with Benzodiazepine Withdrawal Symptoms: A Comparison with Placebo during Diazepam Dose Reduction

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Oxytocin
  • Sponsor:St. Olavs Hospital HF

Bipolar disorder

Not recruiting

Study on Memantine Hydrochloride for Adolescents with Bipolar Disorder

Registered drug
Countries:ItalyItaly
  • Participants:0–17 years
  • Substances:Memantine Hydrochloride
  • Sponsor:Ospedale Pediatrico Bambino Gesu

Study on the Effects of ALZ-801 in Patients Aged 50-80 with Early Alzheimer's Disease and APOE4 Genotype

InvestigationalNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Valiltramiprosate
  • Sponsor:Alzheon Inc.

Fragile X syndrome

Not recruiting

Study on the Effects and Safety of ZYN002 Gel for Children, Adolescents, and Young Adults with Fragile X Syndrome

Investigational
Countries:IrelandIreland
  • Participants:0–17 years · 18–64 years
  • Substances:Cannabidiol
  • Sponsor:Harmony Biosciences Management Inc.

Depression

Not recruiting

Study of nitrous oxide and medical air inhalation in elderly patients with treatment-resistant depression

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Nitrogen
  • Sponsor:Centre Hospitalier Regional Universitaire De Tours

Study on the Effects of Tasimelteon for Patients with Delayed Sleep-Wake Phase Disorder

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Tasimelteon
  • Sponsor:Vanda Pharmaceuticals Inc.

Substances studied in this area

The therapies tested most often in Psychiatric disorders trials.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.